Cargando…

Randomized study between radical surgery and radiotherapy for the treatment of stage IB–IIA cervical cancer: 20-year update

OBJECTIVE: Stage IB–IIA cervical carcinoma can be equally cured either by radical surgery or radiotherapy (RT). Albeit such policies show the same efficacy, they carry a different morbidity. This is an update after 20 years of a previously published randomized trial of RT vs. surgery in the treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Landoni, Fabio, Colombo, Alessandro, Milani, Rodolfo, Placa, Franco, Zanagnolo, Vanna, Mangioni, Costantino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391393/ https://www.ncbi.nlm.nih.gov/pubmed/28382797 http://dx.doi.org/10.3802/jgo.2017.28.e34

Ejemplares similares

Effect of pelvic radiotherapy on patients with stage IB‑IIA cervical cancer after radical hysterectomy: A single‑center retrospective study
por: Ishizawa, Chihiro, et al.
Publicado: (2023)

Radical surgery for stage IB2/IIA2 cervical cancer: A large retrospective study
por: Zhou, Fang, et al.
Publicado: (2022)

Comparison of therapeutic effects of chemo-radiotherapy with neoadjuvant chemotherapy before radical surgery in patients with bulky cervical carcinoma (stage IB3 & IIA2)
por: Akhavan, Setareh, et al.
Publicado: (2021)

Oncologic outcomes of adjuvant chemotherapy alone after radical surgery for stage IB–IIA cervical cancer patients
por: Lee, Kwang-Beom, et al.
Publicado: (2018)

Expression of DNA damage response proteins and complete remission after radiotherapy of stage IB–IIA of cervical cancer
por: Beskow, C, et al.
Publicado: (2006)

Comparison of survival outcomes between radical hysterectomy and definitive radiochemotherapy in stage IB1 and IIA1 cervical cancer
por: Wu, San-Gang, et al.
Publicado: (2017)

Primary radical hysterectomy vs chemoradiation for IB2-IIA cervical cancer: A systematic review and meta-analysis
por: Yan, Ruo-nan, et al.
Publicado: (2020)

Robotic Surgery for Cervical Cancer
por: Magrina, Javier F., et al.
Publicado: (2008)

Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery
por: Zhang, Xiaojing, et al.
Publicado: (2020)

Neoadjuvant chemotherapy followed by radical surgery reduces radiation therapy in patients with stage IB2 to IIA2 cervical cancer
por: Huang, Yuhui, et al.
Publicado: (2022)

Robotic modified radical hysterectomy with pelvic lymphadenectomy
por: Maggioni, A, et al.
Publicado: (2007)

Optimal therapy for IB2 and IIA2 cervical cancer: surgery or chemoradiotherapy?
por: Gaffney, David K.
Publicado: (2012)

Tolerance and efficacy of preoperative intracavitary HDR brachytherapy in IB and IIA cervical cancer
por: Bialas, Brygida, et al.
Publicado: (2009)

Monocytosis as a prognostic factor for survival in stage IB and IIA cervical cancer
por: Eo, Wan Kyu, et al.
Publicado: (2018)

Neoadjuvant Chemotherapy Followed by Radical Surgery versus Radiotherapy (with or without Chemotherapy) in Patients with Stage IB2, IIA, or IIB Cervical Cancer: A Systematic Review and Meta-Analysis
por: Ye, Qingjian, et al.
Publicado: (2020)

Vaginal cuff length during radical hysterectomy is a prognostic factor for stage IB-IIA cervical cancer: a retrospective study
por: Zuo, Na, et al.
Publicado: (2018)

The Effect of Neoadjuvant Chemotherapy Combined With Brachytherapy Before Radical Hysterectomy on Stage IB2 and IIA Cervical Cancer: A Retrospective Analysis
por: Dang, Yun, et al.
Publicado: (2021)

Laparotomic radical hysterectomy versus minimally invasive radical hysterectomy using vaginal colpotomy for the management of stage IB1 to IIA2 cervical cancer: Survival outcomes
por: Yang, Eun Jung, et al.
Publicado: (2022)

Comparison of Oncologic Outcomes between Radical Hysterectomy and Primary Concurrent Chemoradiotherapy in Women with Bulky IB and IIA Cervical Cancer under Risk Stratification
por: Chen, Chung-Shih, et al.
Publicado: (2023)

Optimal use of radiotherapy in the definitive treatment of non-bulky IB–IIA cervical cancer: A population-based long-term survival analysis
por: Lim, Yu Jin, et al.
Publicado: (2021)

Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer
por: Park, Jeong-Yeol, et al.
Publicado: (2012)

Decreased pretreatment lymphocyte/monocyte ratio is associated with poor prognosis in stage Ib1–IIa cervical cancer patients who undergo radical surgery
por: Chen, Liang, et al.
Publicado: (2015)

PET/CT imaging analysis of recurrent sites and patterns of spread following modified radical surgery (type B) for stage Ib-IIa cervical cancer
por: Cheng, Shuxia, et al.
Publicado: (2018)

Clinical outcome of FIGO 2018 stage IB3/IIA2 cervical cancer treated by neoadjuvant chemotherapy followed by radical surgery due to lack of radiotherapy equipment: A retrospective comparison with concurrent chemoradiotherapy
por: Zeng, Jing, et al.
Publicado: (2022)

Cisplatin concurrent chemoradiotherapy vs adjuvant radiation in stage IB/IIA cervical cancer with intermediate risk factors, treated with radical surgery: a retrospective study
por: Sun, Hai-Yan, et al.
Publicado: (2018)

Effect of neoadjuvant chemotherapy followed by radical surgery for FIGO stage IB2/IIA2 cervical cancer: A multi-center retrospective clinical study
por: Zhao, Hui, et al.
Publicado: (2019)

Retrospective analysis of prognosis using the Gynecology Oncology Group score of stage IB-IIA node negative uterine cervical cancer after radical hysterectomy and trachelectomy
por: Kinjo, Yasuyuki, et al.
Publicado: (2022)

Impact of pelvic MRI in routine clinical practice on staging of IB1–IIA2 cervical cancer
por: Zhang, Weifeng, et al.
Publicado: (2019)

The Prognostic Significance Of Pretreatment Albumin/alkaline Phosphatase Ratio In Patients With Stage IB-IIA Cervical Cancer
por: Zhang, Can, et al.
Publicado: (2019)

Chemotherapy versus radiotherapy for FIGO stages IB1 and IIA1 cervical carcinoma patients with postoperative isolated deep stromal invasion: a retrospective study
por: Li, Lei, et al.
Publicado: (2016)

A retrospective comparison of outcome in IB2 and IIA cervical cancer patients treated with primary concurrent chemoradiation versus radical hysterectomy with or without tailored adjuvant therapy
por: Jang, Tae-Kyu, et al.
Publicado: (2017)

Neoadjuvant chemotherapy combined with radical surgery for stage IB2/IIA2 cervical squamous cell carcinoma: a prospective, randomized controlled study of 35 patients
por: Jing, Huang, et al.
Publicado: (2021)

A multicenter non-inferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stages IB1, IB2, and IIA1): study protocol of the LAUNCH 2 trial
por: Wu, Xin, et al.
Publicado: (2022)

Tailoring Pelvic Lymphadenectomy for Patients with Stage IA2, IB1, and IIA1 Uterine Cervical Cancer
por: Zhou, Juan, et al.
Publicado: (2015)

Preoperative fibrinogen-to-albumin ratio, a potential prognostic factor for patients with stage IB-IIA cervical cancer
por: An, Qiang, et al.
Publicado: (2020)

MRI outcome evaluation in patients with IB2 and IIA2 squamous cervical cancer stages: preliminary results
por: Song, Qingling, et al.
Publicado: (2022)

Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study
por: Chen, Xiaolin, et al.
Publicado: (2022)

Chemoradiation with cisplatin followed by either brachytherapy or radical hysterectomy. A non-randomized comparison in FIGO stages IB2-IIA
por: Cetina, Lucely, et al.
Publicado: (2007)

Clinical Role of Adjuvant Chemotherapy after Radical Hysterectomy for FIGO Stage IB-IIA Cervical Cancer: Comparison with Adjuvant RT/CCRT Using Inverse-Probability-of-Treatment Weighting
por: Jung, Phill-Seung, et al.
Publicado: (2015)

Survival outcomes of minimally invasive versus open radical hysterectomy in patients with early-stage IB1 to IIA2 cervical cancer: A single-center retrospective study
por: Yeon Choi, Hwa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p8tb5m20pkg43q85278bu1241b